Basically, if the cost of producing the marginal pill keeps going down, there’s no guarantee that a market negotiation (especially with a near monopsony like Medicare) won’t “[drive] prices down to marginal cost” and be “ruinous”–eg for keeping drug companies in business.
— Mickey Kaus (@kausmickey)
Aug 1, 2022
from Twitter https://twitter.com/kausmickey
August 01, 2022 at 07:28PM
via IFTTT